(EN) Pharmaceutical formulations for use in the administration of medicaments, in particular lipophilic medicaments, via mucosal surfaces. In particular the invention relates to formulations which, upon hydration, form an emulsion containing the lipophilic medicament which is capable of adhering to a mucosal surface and allowing controlled release of the medicament. Also outlined are:
a cannabis-based pharmaceutical formulation comprising the cannabinoids cannabidiol (CBD) and tetrahydrocannabinol (THC) or the cannabinoids tetrahydrocannabinovarin (THCV) and cannabidivarin (CBDV);
and the use of cannabidiol (CBD) to extend the shelf-life of a pharmaceutical product comprising at least one biologically active compound.